Document is current

Should Rapamune (Sirolimus)-Based Immunomodulation Be Given Post Transplant for Those Transplanted for or Found to Have Incidental Hepatocellular Carcinoma?

Crossref DOI link: https://doi.org/10.1007/978-3-031-90225-3_30

Published Online: 2025-07-17

Published Print: 2025

Update policy: https://doi.org/10.1007/springer_crossmark_policy